VETERELIN

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

buserelin acetate

Available from:

Laboratorios Calier, S.A.

Composition:

buserelin acetate 0 g/litre

Therapeutic area:

Endocrine agent (hormone)

Authorization status:

ACVM Registered

Authorization date:

2018-03-05

Summary of Product characteristics

®
T
ype:
Batch:
EXP
.:
Once broached/opened, use within 8
hours.
REF.
00000
[picture of a cow, a mare]
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
VETERELIN
®
0.004
MG/ML
SOLUTION FOR INJECTION FOR CATTLE, HORSES
BUSERELIN (AS BUSERELIN
ACETATE)
QUANTITY OF THE ACTIVE SUBSTANCES:
Buserelin
0.004
mg/ml
(equivalent to
0.0042
mg of Buserelin acetate).
ROUTES OF
ADMINISTRATION:
Preferably by IM, but IV may also be used. For
cattle, horses, SC may also be used.
WITHHOLDING PERIOD:
Meat,
offal, milk: NIL. DANGER Read the package leaflet before use.
RVM
ACVM No. A11478
[Calier logo]
_Top panel (box 5x10ml) _
_____________________________________________________________________ 5X10 ML
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
V
ETER
ELIN
®
0.004
MG/ML
SOLUTION FOR INJECTION FOR
CATTLE,
HORSES
BUSERELIN
(AS BUSERELIN
ACETATE)
Calier logo
_Front panel (box 5x10ml) _
_____________________________________________________________________
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
V
ETER
ELIN
®
0.004
MG/ML
SOLUTION FOR INJECTION FOR
CATTLE,
HORSES
BUSERELIN
(AS BUSERELIN
ACETATE)
Calier logo
_Side panels (box 5x10ml) _
__________________________________________________________________
STATEMENT
OF
ACTIVE
AND OTHER SUBSTANCES:
Active substance: Buserelin
0.004 mg/ml (equivalent
to
0.0042 mg of
Buserelin acetate). Excipient: Benzyl
alcohol (E 1519) 10 mg/ml.
PHARMACEUTICAL FORM:
Solution for injection.
T
ARGET
SPECIES:
Cattle, horses.
INDICATIONS:
For cows: Ovulation
induction or delayed ovulation.
T
reatment
of anoestrus. Treatment of
follicular cysts
with or without symptoms of nymphomania. Improvement of conception
rate in artificial
insemination procedures, also after synchronisation of oestrus with a
PGF2α analogue. Results may
however
vary depending on breeding conditions. For
mares:
Ovulation induction
and thereby
to
synchronise ovulation more closely with mating in mares.
Treatment of anoestrus.
Treatment of follicu